Portfolio Holdings Detail for ISIN IE00BDZVHG35
Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /var/www/liquidata/show_ticker_holding_ETFs.php on line 67
Stock Name / Fund iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer Blackrock

ETF Ticker BTEE(USD) LSE
ETF Ticker BTEE.L(GBP) LSE

Holdings detail for BCYC

Stock Name	Bicycle Therapeutics Ltd
Ticker	BCYC(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US0887861088

Show aggregate BCYC holdings

News associated with BCYC

Bicycle Therapeutics PLC Sponsored ADR (NASDAQ:BCYC) Receives Average Recommendation of “Moderate Buy” from Analysts: Bicycle Therapeutics PLC Sponsored ADR (NASDAQ:BCYC – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the ten ratings firms that are covering the stock, Marketbeat Ratings reports. Three investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The average […] - 2025-07-29 02:14:55
Principal Financial Group Inc. Grows Stake in Bicycle Therapeutics PLC Sponsored ADR (NASDAQ:BCYC): Principal Financial Group Inc. lifted its holdings in Bicycle Therapeutics PLC Sponsored ADR (NASDAQ:BCYC – Free Report) by 55.3% in the first quarter, Holdings Channel reports. The firm owned 631,260 shares of the company’s stock after buying an additional 224,790 shares during the period. Principal Financial Group Inc.’s holdings in Bicycle Therapeutics were worth $5,359,000 […] - 2025-07-17 04:35:03
Analyzing Bicycle Therapeutics (NASDAQ:BCYC) & Galecto (NASDAQ:GLTO): Galecto (NASDAQ:GLTO – Get Free Report) and Bicycle Therapeutics (NASDAQ:BCYC – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, profitability, institutional ownership, valuation, earnings, analyst recommendations and dividends. Profitability This table compares Galecto and Bicycle Therapeutics’ […] - 2025-07-15 06:24:40
Kevin Lee Sells 3,193 Shares of Bicycle Therapeutics PLC Sponsored ADR (NASDAQ:BCYC) Stock: Bicycle Therapeutics PLC Sponsored ADR (NASDAQ:BCYC – Get Free Report) CEO Kevin Lee sold 3,193 shares of the company’s stock in a transaction dated Thursday, July 3rd. The shares were sold at an average price of $7.44, for a total transaction of $23,755.92. Following the transaction, the chief executive officer owned 480,804 shares in the […] - 2025-07-09 07:17:05
Bicycle Therapeutics PLC Sponsored ADR (NASDAQ:BCYC) Receives $25.00 Consensus PT from Analysts: Bicycle Therapeutics PLC Sponsored ADR (NASDAQ:BCYC – Get Free Report) has received an average recommendation of “Moderate Buy” from the ten ratings firms that are presently covering the company, Marketbeat Ratings reports. Three investment analysts have rated the stock with a hold rating and seven have given a buy rating to the company. The average […] - 2025-07-07 02:32:44
Bicycle Therapeutics plc (NASDAQ:BCYC) Stock Holdings Raised by Harbor Capital Advisors Inc.: Harbor Capital Advisors Inc. raised its stake in Bicycle Therapeutics plc (NASDAQ:BCYC – Free Report) by 12.6% in the 1st quarter, according to its most recent filing with the SEC. The fund owned 148,129 shares of the company’s stock after purchasing an additional 16,624 shares during the period. Harbor Capital Advisors Inc.’s holdings in Bicycle […] - 2025-06-13 05:18:56
Bicycle Therapeutics plc (NASDAQ:BCYC) Receives $25.00 Consensus Price Target from Analysts: Bicycle Therapeutics plc (NASDAQ:BCYC – Get Free Report) has been given an average rating of “Moderate Buy” by the ten research firms that are presently covering the stock, Marketbeat reports. Three equities research analysts have rated the stock with a hold rating and seven have issued a buy rating on the company. The average 1 […] - 2025-06-12 02:29:00
Deutsche Bank AG Sells 1,653 Shares of Bicycle Therapeutics plc (NASDAQ:BCYC): Deutsche Bank AG cut its stake in Bicycle Therapeutics plc (NASDAQ:BCYC – Free Report) by 20.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 6,417 shares of the company’s stock after selling 1,653 shares during the period. Deutsche Bank […] - 2025-06-04 04:54:43
Bicycle Therapeutics plc (NASDAQ:BCYC) Given Average Rating of “Moderate Buy” by Analysts: Bicycle Therapeutics plc (NASDAQ:BCYC – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the ten brokerages that are currently covering the company, Marketbeat Ratings reports. Three analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The average 12 month price objective […] - 2025-05-15 02:52:49
Legal & General Group Plc Decreases Stake in Bicycle Therapeutics plc (NASDAQ:BCYC): Legal & General Group Plc lessened its position in Bicycle Therapeutics plc (NASDAQ:BCYC – Free Report) by 41.8% during the fourth quarter, Holdings Channel.com reports. The fund owned 139,075 shares of the company’s stock after selling 99,741 shares during the period. Legal & General Group Plc’s holdings in Bicycle Therapeutics were worth $1,947,000 at the […] - 2025-04-25 05:13:07
Renaissance Technologies LLC Decreases Position in Bicycle Therapeutics plc (NASDAQ:BCYC): Renaissance Technologies LLC cut its stake in shares of Bicycle Therapeutics plc (NASDAQ:BCYC – Free Report) by 1.1% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 269,500 shares of the company’s stock after selling 3,100 shares during the quarter. Renaissance Technologies LLC’s holdings […] - 2025-04-23 05:27:02
Bicycle Therapeutics plc (NASDAQ:BCYC) Receives $29.14 Consensus PT from Brokerages: Shares of Bicycle Therapeutics plc (NASDAQ:BCYC – Get Free Report) have earned an average recommendation of “Moderate Buy” from the eight brokerages that are covering the firm, Marketbeat Ratings reports. Two investment analysts have rated the stock with a hold rating and six have given a buy rating to the company. The average 1-year price […] - 2025-04-23 02:30:48
Needham & Company LLC Reaffirms “Buy” Rating for Bicycle Therapeutics (NASDAQ:BCYC): Needham & Company LLC reiterated their buy rating on shares of Bicycle Therapeutics (NASDAQ:BCYC – Free Report) in a research note issued to investors on Tuesday morning,Benzinga reports. The brokerage currently has a $30.00 price objective on the stock. BCYC has been the subject of several other reports. Stephens reissued an “equal weight” rating and […] - 2025-03-12 04:58:43

iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) BCYC holdings

Date	Number of BCYC Shares Held	Base Market Value of BCYC Shares	Local Market Value of BCYC Shares	Change in BCYC Shares Held	Change in BCYC Base Value	Current Price per BCYC Share Held	Previous Price per BCYC Share Held
2025-12-03 (Wednesday)	33,051	USD 235,984	USD 235,984	0	USD 8,924	USD 7.14	USD 6.86999
2025-12-02 (Tuesday)	33,051	USD 227,060	USD 227,060	1,215	USD 2,935	USD 6.86999	USD 7.03999
2025-12-01 (Monday)	31,836	USD 224,125	USD 224,125	0	USD -14,008	USD 7.03999	USD 7.47999
2025-11-28 (Friday)	31,836	USD 238,133	USD 238,133	81	USD 6,004	USD 7.47999	USD 7.31
2025-11-27 (Thursday)	31,755	USD 232,129	USD 232,129	0	USD 0	USD 7.31	USD 7.31
2025-11-26 (Wednesday)	31,755	USD 232,129	USD 232,129	243	USD 15,642	USD 7.31	USD 6.86999
2025-11-25 (Tuesday)	31,512	USD 216,487	USD 216,487	405	USD 6,826	USD 6.86999	USD 6.73999
2025-11-24 (Monday)	31,107	USD 209,661	USD 209,661	81	USD 13,577	USD 6.73999	USD 6.31999
2025-11-21 (Friday)	31,026	USD 196,084	USD 196,084	0	USD 4,654	USD 6.31999	USD 6.16999
2025-11-20 (Thursday)	31,026	USD 191,430	USD 191,430	-324	USD -4,508	USD 6.16999	USD 6.25002
2025-11-19 (Wednesday)	31,350	USD 195,938	USD 195,938	81	USD -6,372	USD 6.25002	USD 6.46999
2025-11-18 (Tuesday)	31,269	USD 202,310	USD 202,310	486	USD 3,452	USD 6.46999	USD 6.45999
2025-11-17 (Monday)	30,783	USD 198,858	USD 198,858	162	USD 434	USD 6.45999	USD 6.48

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of BCYC by Blackrock for IE00BDZVHG35

Show aggregate share trades of BCYC

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-12-02 BUY 1,215 7.090 6.835 6.861 USD 8,336 10.98
2025-11-28 BUY 81 7.830 7.270 7.326 USD 593 11.01
2025-11-26 BUY 243 7.360 6.760 6.820 USD 1,657 11.05
2025-11-26 BUY 243 7.360 6.760 6.820 USD 1,657 11.05
2025-11-25 BUY 405 6.960 6.710 6.735 USD 2,728 11.07
2025-11-24 BUY 81 6.790 6.300 6.349 USD 514 11.10
2025-11-20 SELL -324 6.750 6.060 6.129 USD -1,986 11.15 Profit of 1,625 on sale
2025-11-19 BUY 81 6.680 6.180 6.230 USD 505 11.17
2025-11-18 BUY 486 6.550 6.170 6.208 USD 3,017 11.20
2025-11-17 BUY 162 6.670 6.300 6.337 USD 1,027 11.22
2025-11-14 BUY 81 6.750 6.430 6.462 USD 523 11.25
2025-11-12 BUY 80 6.880 6.465 6.507 USD 521 11.29
2025-11-10 BUY 80 6.630 6.340 6.369 USD 510 11.34
2025-11-06 BUY 80 6.600 6.230 6.267 USD 501 11.40
2025-11-04 BUY 80 7.335 6.850 6.898 USD 552 11.45
2025-10-30 BUY 400 9.080 7.990 8.099 USD 3,240 11.51
2025-10-29 BUY 160 8.180 8.750 8.693 USD 1,391 11.53
2025-10-22 SELL -316 7.880 8.420 8.366 USD -2,644 11.63 Profit of 1,031 on sale
2025-10-20 BUY 158 8.160 8.390 8.367 USD 1,322 11.67
2025-10-17 BUY 394 8.170 8.730 8.674 USD 3,418 11.69
2025-10-15 BUY 624 8.390 8.500 8.489 USD 5,297 11.71
2025-10-03 BUY 560 8.370 8.680 8.649 USD 4,843 11.75
2025-10-02 BUY 80 8.530 8.690 8.674 USD 694 11.77
2025-09-30 BUY 162 7.740 7.830 7.821 USD 1,267 11.82
2025-09-26 BUY 162 7.400 7.530 7.517 USD 1,218 11.87
2025-09-25 BUY 162 7.540 7.780 7.756 USD 1,256 11.90
2025-09-18 BUY 81 7.160 7.230 7.223 USD 585 11.93
2025-09-17 BUY 243 6.920 7.210 7.181 USD 1,745 11.96
2025-07-17 SELL -158 8.040 8.180 8.166 USD -1,290 12.06 Profit of 615 on sale
2025-07-11 SELL -640 8.000 8.120 8.108 USD -5,189 12.17 Profit of 2,601 on sale
2025-07-02 BUY 4,400 7.440 7.737 7.707 USD 33,912 12.29
2025-06-25 BUY 160 7.100 7.430 7.397 USD 1,184 12.44
2025-06-11 BUY 160 8.760 9.360 9.300 USD 1,488 12.78
2025-06-10 BUY 160 8.640 8.960 8.928 USD 1,428 12.81
2025-06-04 SELL -80 8.460 8.460 8.460 USD -677 12.95 Profit of 359 on sale
2025-04-23 BUY 80 8.670 9.520 9.435 USD 755 14.36
2025-04-10 SELL -640 6.530 6.815 6.787 USD -4,343 15.06 Profit of 5,296 on sale
2025-04-08 SELL -80 6.380 7.280 7.190 USD -575 15.26 Profit of 645 on sale
2025-04-07 SELL -80 6.750 7.085 7.052 USD -564 15.35 Profit of 664 on sale
2025-04-04 SELL -405 6.890 7.410 7.358 USD -2,980 15.45 Profit of 3,279 on sale
2025-04-01 BUY 2,979 7.850 8.420 8.363 USD 24,913 15.63
2025-03-31 SELL -216 8.490 8.900 8.859 USD -1,914 15.72 Profit of 1,482 on sale
2025-03-14 SELL -1,152 9.690 10.320 10.257 USD -11,816 16.72 Profit of 7,442 on sale
2025-03-07 SELL -144 10.230 10.890 10.824 USD -1,559 17.22 Profit of 921 on sale
2025-03-04 SELL -72 10.140 10.670 10.617 USD -764 17.55 Profit of 499 on sale
2025-02-25 BUY 144 11.100 11.480 11.442 USD 1,648 18.11
2025-02-19 SELL -71 12.270 12.397 12.384 USD -879 18.58 Profit of 440 on sale
2025-02-13 BUY 213 12.490 12.660 12.643 USD 2,693 19.07
2025-02-12 BUY 71 12.320 12.450 12.437 USD 883 19.21
2025-02-11 BUY 284 11.640 11.870 11.847 USD 3,365 19.37
2024-12-30 BUY 1,286 14.130 14.875 14.801 USD 19,033 22.26
2024-11-18 SELL -960 20.460 22.180 22.008 USD -21,128 24.43 Profit of 2,324 on sale
2024-11-08 SELL -64 24.960 25.280 25.248 USD -1,616 24.46 Loss of -50 on sale
2024-10-21 SELL -64 26.700 27.255 27.199 USD -1,741 0.00 Loss of -1,741 on sale
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-12-02	BUY	1,215	7.090	6.835	6.861	USD 8,336	10.98
2025-11-28	BUY	81	7.830	7.270	7.326	USD 593	11.01
2025-11-26	BUY	243	7.360	6.760	6.820	USD 1,657	11.05
2025-11-26	BUY	243	7.360	6.760	6.820	USD 1,657	11.05
2025-11-25	BUY	405	6.960	6.710	6.735	USD 2,728	11.07
2025-11-24	BUY	81	6.790	6.300	6.349	USD 514	11.10
2025-11-20	SELL	-324	6.750	6.060	6.129	USD -1,986	11.15 Profit of 1,625 on sale
2025-11-19	BUY	81	6.680	6.180	6.230	USD 505	11.17
2025-11-18	BUY	486	6.550	6.170	6.208	USD 3,017	11.20
2025-11-17	BUY	162	6.670	6.300	6.337	USD 1,027	11.22
2025-11-14	BUY	81	6.750	6.430	6.462	USD 523	11.25
2025-11-12	BUY	80	6.880	6.465	6.507	USD 521	11.29
2025-11-10	BUY	80	6.630	6.340	6.369	USD 510	11.34
2025-11-06	BUY	80	6.600	6.230	6.267	USD 501	11.40
2025-11-04	BUY	80	7.335	6.850	6.898	USD 552	11.45
2025-10-30	BUY	400	9.080	7.990	8.099	USD 3,240	11.51
2025-10-29	BUY	160	8.180	8.750	8.693	USD 1,391	11.53
2025-10-22	SELL	-316	7.880	8.420	8.366	USD -2,644	11.63 Profit of 1,031 on sale
2025-10-20	BUY	158	8.160	8.390	8.367	USD 1,322	11.67
2025-10-17	BUY	394	8.170	8.730	8.674	USD 3,418	11.69
2025-10-15	BUY	624	8.390	8.500	8.489	USD 5,297	11.71
2025-10-03	BUY	560	8.370	8.680	8.649	USD 4,843	11.75
2025-10-02	BUY	80	8.530	8.690	8.674	USD 694	11.77
2025-09-30	BUY	162	7.740	7.830	7.821	USD 1,267	11.82
2025-09-26	BUY	162	7.400	7.530	7.517	USD 1,218	11.87
2025-09-25	BUY	162	7.540	7.780	7.756	USD 1,256	11.90
2025-09-18	BUY	81	7.160	7.230	7.223	USD 585	11.93
2025-09-17	BUY	243	6.920	7.210	7.181	USD 1,745	11.96
2025-07-17	SELL	-158	8.040	8.180	8.166	USD -1,290	12.06 Profit of 615 on sale
2025-07-11	SELL	-640	8.000	8.120	8.108	USD -5,189	12.17 Profit of 2,601 on sale
2025-07-02	BUY	4,400	7.440	7.737	7.707	USD 33,912	12.29
2025-06-25	BUY	160	7.100	7.430	7.397	USD 1,184	12.44
2025-06-11	BUY	160	8.760	9.360	9.300	USD 1,488	12.78
2025-06-10	BUY	160	8.640	8.960	8.928	USD 1,428	12.81
2025-06-04	SELL	-80	8.460	8.460	8.460	USD -677	12.95 Profit of 359 on sale
2025-04-23	BUY	80	8.670	9.520	9.435	USD 755	14.36
2025-04-10	SELL	-640	6.530	6.815	6.787	USD -4,343	15.06 Profit of 5,296 on sale
2025-04-08	SELL	-80	6.380	7.280	7.190	USD -575	15.26 Profit of 645 on sale
2025-04-07	SELL	-80	6.750	7.085	7.052	USD -564	15.35 Profit of 664 on sale
2025-04-04	SELL	-405	6.890	7.410	7.358	USD -2,980	15.45 Profit of 3,279 on sale
2025-04-01	BUY	2,979	7.850	8.420	8.363	USD 24,913	15.63
2025-03-31	SELL	-216	8.490	8.900	8.859	USD -1,914	15.72 Profit of 1,482 on sale
2025-03-14	SELL	-1,152	9.690	10.320	10.257	USD -11,816	16.72 Profit of 7,442 on sale
2025-03-07	SELL	-144	10.230	10.890	10.824	USD -1,559	17.22 Profit of 921 on sale
2025-03-04	SELL	-72	10.140	10.670	10.617	USD -764	17.55 Profit of 499 on sale
2025-02-25	BUY	144	11.100	11.480	11.442	USD 1,648	18.11
2025-02-19	SELL	-71	12.270	12.397	12.384	USD -879	18.58 Profit of 440 on sale
2025-02-13	BUY	213	12.490	12.660	12.643	USD 2,693	19.07
2025-02-12	BUY	71	12.320	12.450	12.437	USD 883	19.21
2025-02-11	BUY	284	11.640	11.870	11.847	USD 3,365	19.37
2024-12-30	BUY	1,286	14.130	14.875	14.801	USD 19,033	22.26
2024-11-18	SELL	-960	20.460	22.180	22.008	USD -21,128	24.43 Profit of 2,324 on sale
2024-11-08	SELL	-64	24.960	25.280	25.248	USD -1,616	24.46 Loss of -50 on sale
2024-10-21	SELL	-64	26.700	27.255	27.199	USD -1,741	0.00 Loss of -1,741 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of BCYC

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	26,387	0	87,238	30.2%
2025-09-18	16,319	0	141,609	11.5%
2025-09-17	12,243	0	69,266	17.7%
2025-09-16	13,372	0	117,491	11.4%
2025-09-15	25,739	100	73,985	34.8%
2025-09-12	29,520	0	155,861	18.9%
2025-09-11	44,092	0	156,843	28.1%
2025-09-10	36,245	0	96,660	37.5%
2025-09-09	16,517	0	80,856	20.4%
2025-09-08	26,752	150	74,304	36.0%
2025-09-05	8,223	0	54,950	15.0%
2025-09-04	23,533	0	100,971	23.3%
2025-09-03	9,971	0	56,316	17.7%
2025-09-02	15,920	0	62,937	25.3%
2025-08-29	53,125	0	144,350	36.8%
2025-08-28	10,028	0	51,174	19.6%
2025-08-27	22,088	0	62,537	35.3%
2025-08-26	19,969	0	62,726	31.8%
2025-08-25	22,466	0	80,682	27.8%
2025-08-22	18,441	0	77,092	23.9%
2025-08-21	6,031	0	67,761	8.9%
2025-08-20	14,315	0	63,382	22.6%
2025-08-19	24,381	254	67,901	35.9%
2025-08-18	47,160	0	118,001	40.0%
2025-08-15	24,405	0	78,262	31.2%
2025-08-14	36,680	0	202,168	18.1%
2025-08-13	74,001	31	259,617	28.5%
2025-08-12	26,896	0	102,382	26.3%
2025-08-11	15,761	0	65,783	24.0%
2025-08-08	66,916	0	127,616	52.4%
2025-08-07	19,839	0	44,352	44.7%
2025-08-06	21,165	0	71,991	29.4%
2025-08-05	20,479	0	71,056	28.8%
2025-08-04	15,909	0	51,912	30.6%
2025-08-01	14,179	0	38,073	37.2%
2025-07-31	21,855	0	110,108	19.8%
2025-07-30	18,755	19	68,708	27.3%
2025-07-29	28,399	145	209,638	13.5%
2025-07-28	29,378	0	78,996	37.2%
2025-07-25	20,752	0	73,818	28.1%
2025-07-24	17,151	0	73,850	23.2%
2025-07-23	39,266	0	137,330	28.6%
2025-07-22	22,721	0	193,789	11.7%
2025-07-21	28,837	0	135,604	21.3%
2025-07-18	45,393	0	263,435	17.2%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Stock Name / Fund	iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer	Blackrock
ETF Ticker	BTEE(USD) LSE
ETF Ticker	BTEE.L(GBP) LSE